CYP26A1 and colorectal carcinoma: In addition to the higher CYP26A1 expression and the consequential AtRA resistance, as CRC progresses, RAR β was downregulated in mice bearing mutations in the Apc tumor suppressor gene (ApcMIN mouse), human FAP adenomas, and human sporadic colon carcinomas [86, 87].